Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H8N4O4 |
Molecular Weight | 248.1949 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC(=CN1C2=CC=C(C=C2)[N+]([O-])=O)[N+]([O-])=O
InChI
InChIKey=NMTBSNPBIGRZBL-UHFFFAOYSA-N
InChI=1S/C10H8N4O4/c1-7-11-10(14(17)18)6-12(7)8-2-4-9(5-3-8)13(15)16/h2-6H,1H3
Nitrefazole (2-methyl-4-nitro-1-(4-nitro-phenyl)imidazole, Altimol) is a strong and long lasting inhibitor of aldehyde dehydrogenase, an enzyme involved in the metabolism of alcohol. It was used for the treatment of alcoholism as an alcohol-sensitizing agent (alcohol deterrent). Nitrefazole was introduced in the early 1980s. By 1984 its use had been associated with hepatotoxic reactions, some of which were fatal. This lets to its withdrawal. WHO has no information to suggest that preparations containing nitrefazole remain commercially available.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3542434 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | ALTIMOL Approved UseNitrefazole (2-methyl-4-nitro-1-(4-nitro-phenyl)imidazole, Altimol) was used for the treatment of alcoholism as an alcohol-sensitizing agent. Launch Date1983 |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C471
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C72626
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
PRIMARY | |||
|
C013756
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
PRIMARY | |||
|
1946
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
PRIMARY | |||
|
m371
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB09319MIG
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
PRIMARY | |||
|
5031
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
PRIMARY | |||
|
CHEMBL1909285
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
PRIMARY | |||
|
244-542-8
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
PRIMARY | |||
|
VFD629099M
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
PRIMARY | |||
|
71900
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
PRIMARY | |||
|
DTXSID2048826
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
PRIMARY | |||
|
21721-92-6
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
PRIMARY | |||
|
100000084139
Created by
admin on Fri Dec 15 16:24:40 GMT 2023 , Edited by admin on Fri Dec 15 16:24:40 GMT 2023
|
PRIMARY |
ACTIVE MOIETY